「先駆け審査指定制度」に基づき、医療機器（３品目）、体外診断用医薬品（１品目）及び再生医療等製品（３品目）を指定 ｜報道発表資料｜厚生労働省

This page is a press release from the Ministry of Health, Labour and Welfare dated February 28, 2017, announcing seven products designated under the "Pioneering Review Designation System." These include three medical devices, one in vitro diagnostic product, and three regenerative medicine products. The system aims to enable early practical application of innovative products in Japan, reducing the standard review period from 12 months to 6 months. Designated products include those developed from university research and by domestic SMEs and venture companies, expected to promote innovation and economic growth.